News and innovations published by German exhibitorsback to overview
The Regensburg Center for Interventional Immunology (RCI) is being accommodated at the BioPark until the completion of the new research building. Here the foundations for the development of new immunotherapies will be researched, to make therapeutic interventions for cancer, infectious diseases, autoimmune diseases as well as organ and stem cells transplants possible.
The Regensburg Center for Interventional Immunology (RCI) was founded in 2010 as a central institution at the University of Regensburg to bring together all the University research fields working on the development of new immunotherapies.
Until completion of the new research building, the BioPark Regensburg GmbH, an enterprise of the City of Regensburg, is supporting the expansion the RCI with floor space at the BioPark.
The goal of the RCI is the research, development and rapid implementation of improved therapeutic interventions for cancer, infectious diseases, autoimmune disease as well as in organ and stem cell transplantation.
Exhibitor: BioPark Regensburg